Connect with us

Hi, what are you looking for?

Politics

Senate committee to vote on Dr. Oz’s nomination to run the Centers for Medicare and Medicaid Services

The Senate Committee on Finance is set to vote later Tuesday afternoon on whether to advance President Donald Trump’s pick to lead the Centers for Medicare and Medicaid Services, Dr. Mehmet Oz, to a full Senate confirmation vote. 

The vote follows two hearings by the committee that probed Oz over his plans for the federal healthcare programs, his views on abortion, potential conflicts of interest in the healthcare industry and more.   

If confirmed, Oz would be in charge of nearly $1.5 trillion in federal healthcare spending. Medicare, a federal healthcare program for seniors aged 65 and up, currently provides coverage for about 65 million Americans, according to the Center for Medicare Advocacy. Medicaid, which assists people with low incomes, covers roughly 72 million Americans, according to Medicaid.gov.

A former heart surgeon who saw his fame rise through his appearances on daytime TV and 13 seasons of ‘The Dr Oz Show,’ Oz later transitioned into politics, launching an unsuccessful bid for Pennsylvania’s open Senate seat in 2022. He ultimately lost to John Fetterman, then the state’s lieutenant governor. 

Oz graduated from Harvard and received medical and business degrees from the University of Pennsylvania.

As the administrator of CMS, Oz would make decisions related to how the government covers procedures, hospital stays and medication within the federal healthcare programs, as well as the reimbursement rates at which healthcare providers get paid for their services.

Earlier this month, Trump’s pick to lead the NIH and FDA, Dr. Jay Bhattacharya and Dr. Marty Makary, respectively, were also approved in committee and are awaiting full confirmation votes in the Senate. 

Around the same time that Bhattacharya and Makary won committee approval, Trump withdrew his nomination of former Florida Rep. David Weldon to run the CDC, over fears he did not have the GOP support to clear full confirmation. 

On Monday, the Trump administration named Susan Monarez, acting director of the CDC, as its new nominee.

This post appeared first on FOX NEWS

    You May Also Like

    Stock

    Technology companies pick China for production primarily because it offers lower labour costs. That’s the widespread conception, or perhaps a “misconception” as Tim Cook,...

    Politics

    White House trade advisor Peter Navarro brushed off concerns about a feud between him and billionaire Elon Musk, arguing the two administration advisors had...

    Investing

    Embattled genetic testing company 23andMe, once valued at $6 billion, filed for Chapter 11 bankruptcy protection in Missouri federal court on Sunday night. The company’s...

    Economy

    Meme coins remained under pressure this month as market participants watched the ongoing trade war between the US and China. Bitcoin price was trading...